Company intelligence / Profile preview

Bakhtar Bioshimi

Ownership
Private
Development stage
Other
01

Overview

Bakhtar Bioshimi is a fully integrated pharmaceutical manufacturing company in Iran, established in 1989, producing various chemical medicines and pharmaceutical products. It is actively involved in the import and export of pharmaceutical bulk drugs, sourcing from international suppliers like Sun Pharmaceutical Industries and Hetero Drugs[1][2][3][4].

Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

3 assets

Sobayovivo

Unknown

2 more assets in the full pipeline.

03

Partnerships

Collaborates with suppliers such as Sun Pharmaceutical Industries LtdHetero Drugs LimitedHetero Labs Limited[1]

Beyond the preview

Go deeper on Bakhtar Bioshimi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bakhtar Bioshimi.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call